Skip to main content

Karyopharm Therapeutics Inc 8-K, filed Nov 2, 2026

Karyopharm Therapeutics Inc. (KPTI)

8-K 2026-11-02 For: 2026-11-02
View Original
Added on November 02, 2026

About this 8-K

Karyopharm Therapeutics Inc filed this 8-K on November 2, 2026.

Karyopharm Therapeutics Inc. plans a merger with Ayrmid Ltd. and filed Chapter 11 petitions. The deal is expected to close in the first quarter of 2027 with up to $55 million in DIP financing; equity is expected to have no value. AI summary

Items reported

  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits